Study Day | Group 11 AM2 (n3) | Group 21 AM2 (n3) | % Efficacy4 | p-Value5 |
2 | 24.5 (8) | 0 (8) | 100 | <0.0001 |
9 | 21.6 (8) | 0 (8) | 100 | <0.0001 |
30 | 26.5 (8) | 0.9 (8) | 96.7 | <0.0001 |
Study Day | Group 11 AM2 (n3) | Group 31 AM2 (n3) | % Efficacy4 | p-Value5 |
2 | 24.5 (8) | 0 (7) | 100 | <0.0001 |
9 | 21.6 (8) | 0 (6) | 100 | <0.0001 |
30 | 26.5 (8) | 0 (6) | 100 | <0.0001 |